MedPath

Role of Mesh in Laparoscopic Sacropexy Surgical Techniques for the Treatment of Female Genital Prolapse

Recruiting
Conditions
Female Genital Prolapse
Registration Number
NCT06720831
Lead Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Brief Summary

This study aims to determine the rate of recurrence of central pelvic organ prolapse in patients who have undergone surgery (sacropexy with and without mesh) for the same pathology.

Detailed Description

There is a lack of data in the literature comparing sacroplexing with the use of mesh with sacroplexing performed without the use of mesh in terms of recurrence, improvement in symptoms, and restoration of normal pelvic organ prolapse relationships. The objective of this study is to determine the rate of recurrence of central pelvic organ prolapse in patients with a clinical diagnosis of genital prolapse stage ≥ 2 according to the POP-Q classification who underwent laparoscopic sacroplasty with mesh (group 1) and without mesh (group 2). The study may provide information on the impact of mesh in laparoscopic surgery for the correction of central pelvic organ prolapse.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
160
Inclusion Criteria
  • Age ≥ 18 years
  • Clinical diagnosis of genital prolapse stage ≥ 2 according to POP-Q classification
  • Surgical treatment of laparoscopic sacropexy by mesh (group 1) and without (group 2) in female patients
  • Acquisition of informed consent
  • At least one follow-up evaluation at 24 months
Exclusion Criteria
  • Age > 80 years
  • Previous genital prolapse surgery

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrence rate of central pelvic organ prolapse24 months after surgery

The rate of recurrence of central pelvic organ prolapse in patients with a clinical diagnosis of genital prolapse stage ≥ 2 according to the POP-Q classification, undergoing sacroplasty with and without mesh

Secondary Outcome Measures
NameTimeMethod
Recurrence rate of central pelvic organ prolapse in laparoscopic sacral hysteropexy, sacralcervicopexy and sacralcolpopexy24 months after surgery

The rate of pelvic organ prolapse recurrence in patients treated with mesh (group 1) and without (group 2) in the laparoscopic sacral hysteropexy, sacralcervicopexy and sacralcolpopexy

Rate of intraoperative and postoperative complicationsDuring surgery and within 30 days

Evaluation of intraoperative and postoperative complications according to the Clavien-Dindo classification

Modification of symptoms after surgeryBefore surgery and 24 months after surgery

Change in pre- and post-operative symptomatology assessed through the completion of a questionnaire

Changes in the disease frameworkBefore surgery and 24 months after surgery

Change in the disease framework of pelvic organ prolapse according to the POP-Q classification assessed before and after surgery

Trial Locations

Locations (2)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

🇮🇹

Bologna, Italy

Azienda Ospedaliera Universitaria Integrata di Verona

🇮🇹

Verona, Italy

© Copyright 2025. All Rights Reserved by MedPath